Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 175   

Articles published

GSK 1,473.50 +10.50 (0.72%)
price chart
The Benefits Of Investing In GlaxoSmithKline plc
Ongoing fears over corruption allegations across the world has dominated investor sentiment towards medicine giant GlaxoSmithKline during the past 12 months. The share price has failed to gain significant traction as a result, and the firm has ...
Deutsche Bank Reiterates Hold Rating for GlaxoSmithKline plc (GSK)  WKRB News
GlaxoSmithKline plc Given Consensus Recommendation of �Hold� by ...  Ticker Report
Related articles »  
What You Were Buying Last Week: GlaxoSmithKline plc
One of Warren Buffett's famous investing sayings is �be fearful when others are greedy and greedy only when others are fearful�.
Related articles »  
HSBC Holdings plc, GlaxoSmithKline plc, BP plc & BHP Billiton plc Are Holding ...
Over in the US, the benchmark S&P 500 index surged to an all-time high this week, while the Dow Jones Industrial average is following close behind.
At What Price Would GlaxoSmithKline plc Be A Bargain Buy?
gsk Patience is one of the key attributes of a successful investor. The likes of US master Warren Buffett have been known to wait years for the right company at the right price.
1 Reason I Wouldn't Buy GlaxoSmithKline plc Today
GlaxoSmithKline remains stuck between a rock and a hard place as allegations of improper conduct spread across its global operations continue to grow.
Related articles »  
3 Shares To Get Rich: GlaxoSmithKline plc, National Grid plc And Lloyds ...
Even though the FTSE 100 has pulled back in recent weeks and the future looks decidedly uncertain, in the long run investing in shares should pay off.
Related articles »  
GlaxoSmithKline plc's Dividends Are Rising Nicely
Big pharmaceuticals companies like GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have been relied on for decades to provide steady dividend income, and with the company having provided a 4.8% yield last year, it's not hard to see why.
Related articles »  
Here's Why You Need GlaxoSmithKline plc In Your Portfolio
There's no doubt that GlaxoSmithKline's (LSE: GSK) (NYSE: GSK.US) future is uncertain. After being accused of using bribes to sell its treatments within several markets, the biotechnology giant is now under investigation by the Serious Fraud Office.
3 Reasons GlaxoSmithKline plc Stock Could Rise
Like most big pharmas these days, the U.K.'s GlaxoSmithKline (NYSE: GSK ) is going through a transitory period as key medicines like Advair and Lovaza lose market share to new products.
If You Want Dividend Income, Look No Further than GlaxoSmithKline plc Stock  NASDAQ
Related articles »  
GlaxoSmithKline plc Is The Ideal Dividend Investment
I've never quite been able to make up my mind about GlaxoSmithKline (LSE: GSK). It's one of the world's leading pharmaceutical companies, with perhaps the strongest drugs pipeline in pharma.